255 related articles for article (PubMed ID: 6359378)
41. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
42. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
Mäkelä PH; Leinonen M; Pukander J; Karma P
Rev Infect Dis; 1981; 3 Suppl():S124-32. PubMed ID: 6974386
[TBL] [Abstract][Full Text] [Related]
43. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
Toltzis P; Jacobs MR
Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
[TBL] [Abstract][Full Text] [Related]
44. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
Jokinen JT; Ahman H; Kilpi TM; Mäkelä PH; Käyhty MH
J Infect Dis; 2004 Aug; 190(3):545-50. PubMed ID: 15243930
[TBL] [Abstract][Full Text] [Related]
45. New vaccines for the prevention of pneumococcal infections.
Käyhty H; Eskola J
Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
[TBL] [Abstract][Full Text] [Related]
46. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
Eskola J
Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
[TBL] [Abstract][Full Text] [Related]
47. Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy.
Giebink GS; Berzins IK; Quie PG
Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):339-43. PubMed ID: 6778342
[TBL] [Abstract][Full Text] [Related]
48. Vaccination trials in otitis media: experiences in Finland since 1977.
Mäkelä PH; Karma P
Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S79-82. PubMed ID: 2648300
[No Abstract] [Full Text] [Related]
49. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.
Sloyer JL; Ploussard JH; Howie VM
Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444
[TBL] [Abstract][Full Text] [Related]
50. Pneumococcal vaccination. Controversies and opportunities.
Spika JS; Fedson DS; Facklam RR
Infect Dis Clin North Am; 1990 Mar; 4(1):11-27. PubMed ID: 2407776
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of pneumococcal vaccine.
Le C
JAMA; 2000 Jul; 284(4):440; author reply 440-1. PubMed ID: 10904499
[No Abstract] [Full Text] [Related]
52. Beneficial effect of pneumococcal vaccination on otitis media in children over two years old.
Rosén C; Christensen P; Henrichsen J; Hovelius B; Prellner K
Int J Pediatr Otorhinolaryngol; 1984 Jul; 7(3):239-46. PubMed ID: 6480233
[TBL] [Abstract][Full Text] [Related]
53. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
Giebink GS; Koskela M; Vella PP; Harris M; Le CT
J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
[TBL] [Abstract][Full Text] [Related]
54. Antibody response of young children to parenteral vaccination with pneumococcal capsular polysaccharides: a comparison between antibody levels in serum and middle ear effusion.
Koskela M
Pediatr Infect Dis; 1986; 5(4):431-4. PubMed ID: 3755238
[TBL] [Abstract][Full Text] [Related]
55. The assessment of pneumococcal vaccine.
Austrian R
N Engl J Med; 1980 Sep; 303(10):578-80. PubMed ID: 7402223
[No Abstract] [Full Text] [Related]
56. Acute mastoiditis in the pneumococcal conjugate vaccine era.
Tamir SO; Roth Y; Dalal I; Goldfarb A; Marom T
Clin Vaccine Immunol; 2014 Aug; 21(8):1189-91. PubMed ID: 24920600
[TBL] [Abstract][Full Text] [Related]
57. Pneumococcal vaccine in otitis media.
Mäkelä PH; Karma P
Lancet; 1981 Jan; 1(8212):152-3. PubMed ID: 6109824
[No Abstract] [Full Text] [Related]
58. Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group.
Teele DW; Klein JO; Bratton L; Fisch GR; Mathieu OR; Porter PJ; Starobin SG; Tarlin LD; Younes RP
Rev Infect Dis; 1981; 3 Suppl():S113-8. PubMed ID: 7280443
[TBL] [Abstract][Full Text] [Related]
59. Antibody activity before and after pneumococcal vaccination of otitis-prone and non-otitis-prone children.
Kalm O; Prellner K; Freijd A; Rynnel-Dagöö B
Acta Otolaryngol; 1986; 101(5-6):467-74. PubMed ID: 3727981
[TBL] [Abstract][Full Text] [Related]
60. Oral vaccine therapy for pneumococcal otitis media in an animal model.
Yoshimura H; Watanabe N; Bundo J; Shinoda M; Mogi G
Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):889-94. PubMed ID: 1892622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
